risedronic acid has been researched along with Sclerosis, Systemic in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botzoris, VG | 1 |
| Argyropoulou, MI | 1 |
| Voulgari, PV | 1 |
| Zikou, AK | 1 |
| Drosos, AA | 1 |
1 review available for risedronic acid and Sclerosis, Systemic
| Article | Year |
|---|---|
Heterotopic ossification in systemic sclerosis.
Topics: Acetaminophen; Colchicine; Drug Therapy, Combination; Etidronic Acid; Humans; Knee Joint; Male; Midd | 2009 |